Cargando…

MR-Proadrenomedullin as biomarker of renal damage in urinary tract infection in children

BACKGROUND: Midregional-proadrenomedullin (MR-proADM) is a useful prognostic peptide in severe infectious pathologies in the adult population. However, there are no studies that analyze its utility in febrile urinary tract infection (fUTI) in children. An accurate biomarker would provide an early de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peñalver Penedo, Rafael, Rupérez Lucas, Marta, Álvarez-Sala Walther, Luis Antonio, Torregrosa Benavent, Alicia, Casas Losada, María Luisa, Bañuelos Andrio, Luis, Rebolledo Poves, Ana Belén, Bueno Campaña, Mercedes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240321/ https://www.ncbi.nlm.nih.gov/pubmed/34187408 http://dx.doi.org/10.1186/s12887-021-02765-2

Ejemplares similares

Procalcitonin, MR-Proadrenomedullin, and Cytokines Measurement in Sepsis Diagnosis: Advantages from Test Combination
por: Angeletti, Silvia, et al.
Publicado: (2015)

Usefulness of Midregional Proadrenomedullin to Predict Poor Outcome in Patients with Community Acquired Pneumonia
por: Gordo-Remartínez, Susana, et al.
Publicado: (2015)

Initial levels of mr-proadrenomedullin: a predictor of severity in patients with influenza a virus pneumonia
por: Valenzuela Sanchez, F, et al.
Publicado: (2015)

Diagnostic and prognostic value of proadrenomedullin in neonatal sepsis
por: Fahmey, Sameh Samir, et al.
Publicado: (2018)

The kinetic profiles of copeptin and mid regional proadrenomedullin (MR-proADM) in pediatric lower respiratory tract infections
por: Baumann, Philipp, et al.
Publicado: (2022)

Increasing the Contrast of the Brain MR FLAIR Images Using Fuzzy Membership Functions and Structural Similarity Indices in Order to Segment MS Lesions
por: Bijar, Ahmad, et al.
Publicado: (2013)

Prognostic value of proadrenomedullin in patients with COVID-19 pneumonia
por: Astapovskii, Aleksandr A., et al.
Publicado: (2022)

Usefulness of Preoperative Determination of Serum MR-ProAdrenomedullin Levels to Predict the Need for Postoperative Organ Support in Abdominal Oncological Surgery
por: Ramasco Rueda, Fernando, et al.
Publicado: (2023)

Proadrenomedullin in Sepsis and Septic Shock: A Role in the Emergency Department
por: Piccioni, Andrea, et al.
Publicado: (2021)

Procalcitonin, pyuria and proadrenomedullin in the management of urinary tract infections – ‘triple p in uti’: study protocol for a randomized controlled trial
por: Drozdov, Daniel, et al.
Publicado: (2013)

Procalcitonin, mid-regional proadrenomedullin and C-reactive protein in predicting treatment outcome in community-acquired febrile urinary tract infection
por: Stalenhoef, Janneke Evelyne, et al.
Publicado: (2019)

Proadrenomedullin and copeptin in pediatric pneumonia: a prospective diagnostic accuracy study
por: Alcoba, Gabriel, et al.
Publicado: (2015)

Mid-Regional Proadrenomedullin (MR-proADM) and Microcirculation in Monitoring Organ Dysfunction of Critical Care Patients With Infection: A Prospective Observational Pilot Study
por: Domizi, Roberta, et al.
Publicado: (2021)

Mid-Regional Proadrenomedullin as a New Biomarker of Kidney and Cardiovascular Diseases—Is It the Future?
por: Czajkowska, Katarzyna, et al.
Publicado: (2021)

Prognostic value of copeptin and mid‐regional proadrenomedullin in COVID‐19‐hospitalized patients
por: Indirli, Rita, et al.
Publicado: (2022)

The role of proadrenomedullin, interleukin 6 and CD64 in the diagnosis and prognosis of septic shock
por: Turan, Yasemin Bozkurt
Publicado: (2023)

Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia
por: Suberviola, B, et al.
Publicado: (2011)

Acute exacerbations of copd (AECOPD) in the emergency room (ER): prognostic value of proadrenomedulline (PROADM)
por: Dres, M, et al.
Publicado: (2015)

Diagnostic and Prognostic Validity of Proadrenomedullin among Neonates with Sepsis in Tertiary Care Hospitals of Southern India
por: Kannan, Raja, et al.
Publicado: (2018)

Superior accuracy of mid-regional proadrenomedullin for mortality prediction in sepsis with varying levels of illness severity
por: Andaluz-Ojeda, David, et al.
Publicado: (2017)

Proadrenomedullin in Patients with Preserved Left Ventricular Systolic Function Undergoing Coronary Artery Bypass Grafting
por: Stanisz-Kempa, Joanna, et al.
Publicado: (2022)

A Pilot Study on the Diagnostic Accuracy of Proadrenomedullin and Proatrial Natriuretic Peptide in Lower Respiratory Tract Infections
por: Ruiz-González, Agustín, et al.
Publicado: (2014)

Midregional Proadrenomedullin Can Reflect the Accumulation of Visceral Adipose Tissue—A Key to Explaining the Obesity Paradox
por: Koyama, Teruhide, et al.
Publicado: (2020)

Kinetics and Role of Pancreatic Stone Protein and Midregional Proadrenomedullin as Predictors of Sepsis and Bacteremia in Children with Hematological Malignancies
por: Antari, Vasiliki, et al.
Publicado: (2023)

Proadrenomedullin N-Terminal 20 Peptides (PAMPs) Are Agonists of the Chemokine Scavenger Receptor ACKR3/CXCR7
por: Meyrath, Max, et al.
Publicado: (2021)

Endothelial dysfunction and Mid-Regional proAdrenomedullin: What role in SARS-CoV-2 infected Patients?
por: Zaninotto, Martina, et al.
Publicado: (2021)

Midregional Proadrenomedullin Improves Risk Stratification beyond Surgical Risk Scores in Patients Undergoing Transcatheter Aortic Valve Replacement
por: Csordas, Adam, et al.
Publicado: (2015)

The effect of adrenomedullin and proadrenomedullin N-terminal 20 peptide on angiotensin II induced vascular smooth muscle cell proliferation
por: Ma, Jian, et al.
Publicado: (2016)

Prognostic value of serum proadrenomedullin in catheter-related bloodstream infection in the intensive care unit: A prospective observational study
por: Ni, Juping, et al.
Publicado: (2018)

High value of mid‐regional proadrenomedullin in COVID‐19: A marker of widespread endothelial damage, disease severity, and mortality
por: Spoto, Silvia, et al.
Publicado: (2021)

The Role of Mid-Regional Proadrenomedullin in the Differential Diagnosis between Culture-Negative and Culture-Positive Sepsis at Emergency Department Admission
por: Mearelli, Filippo, et al.
Publicado: (2022)

Mid-regional Proadrenomedullin Biomarker Predicts Coronavirus Disease 2019 Clinical Outcomes: A US-Based Cohort Study
por: Atallah, Natalie J, et al.
Publicado: (2022)

Circulating mid-regional proadrenomedullin is a predictor of mortality in patients with COVID-19: a systematic review and meta-analysis
por: Wang, Na, et al.
Publicado: (2023)

Comprehensive Assessment of Mid-Regional Proadrenomedullin, Procalcitonin, Neuron-Specific Enolase and Protein S100 for Predicting Pediatric Severe Trauma Outcomes
por: Zakirov, Rustam, et al.
Publicado: (2023)

Red cell distribution width as a prognostic marker for complications of community-acquired pneumonia in children: a comparison with Proadrenomedullin and Copeptin
por: Moustafa, Asmaa N., et al.
Publicado: (2023)

Mr. Howship on Diseases of the Urinary Organs
Publicado: (1823)

Mr. Howship, on the Diseases of the Urinary Organs
Publicado: (1816)

Effectiveness of Proadrenomedullin Enhanced CURB65 Score Algorithm in Patients with Community-Acquired Pneumonia in “Real Life”, an Observational Quality Control Survey
por: Widmer, Daniel, et al.
Publicado: (2014)

Synergistic effect of myocardial injury and mid-regional proAdrenomedullin elevation in determining clinical outcomes of SARS-CoV-2 patients
por: Spoto, Silvia, et al.
Publicado: (2022)

Tratamientos farmacológicos de los pacientes con COVID19: interacciones e indicaciones
por: Iglesias, Mercedes, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_voc76980i76kvn98mrgskeevd4